Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9165273rdf:typepubmed:Citationlld:pubmed
pubmed-article:9165273lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:9165273lifeskim:mentionsumls-concept:C0229951lld:lifeskim
pubmed-article:9165273lifeskim:mentionsumls-concept:C0814999lld:lifeskim
pubmed-article:9165273lifeskim:mentionsumls-concept:C0206527lld:lifeskim
pubmed-article:9165273lifeskim:mentionsumls-concept:C1553412lld:lifeskim
pubmed-article:9165273lifeskim:mentionsumls-concept:C1548328lld:lifeskim
pubmed-article:9165273pubmed:issue3-4lld:pubmed
pubmed-article:9165273pubmed:dateCreated1997-7-18lld:pubmed
pubmed-article:9165273pubmed:abstractTextIt is generally accepted that thymic epithelial cells (TEC) act as accessory cells in positive selection of pre-T cells. However, our knowledge of the antigen presentation and accessory cell function to human TEC is limited. Here we present results obtained by the use of serum-free cultured human TEC, showing that IFN-gamma-treated TEC are able to support T-cell-mediated responses to the bacterial superantigens (Sag) SEA and SEB, even at very low Sag concentrations. T-cell responses to TEC-presented Sags were dependent on the presence of the adhesion molecules ICAM-1, ICAM-2, LFA-1, and LFA-3, but not on CD4 and CD8 molecules. There is a low but significant expression of B7 molecules on human TEC, and treatment of TEC with anti-B7.1 and anti-B7.2 antibodies before Sag pulsing leads to decreased Sag responses, indicating a significant importance of B7 molecules on TEC. Both CD4+ T-cell lines and CD4+ as well as CD8+ subpopulations of thymocytes showed significant responses, whereas nonseparated thymocytes, CD4+8+, and CD4-CD8- thymocytes did not respond or showed very low responses. In conclusion, the present results demonstrate that cultured human TEC are able to present Sag to thymocytes.lld:pubmed
pubmed-article:9165273pubmed:languageenglld:pubmed
pubmed-article:9165273pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9165273pubmed:citationSubsetIMlld:pubmed
pubmed-article:9165273pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9165273pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9165273pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9165273pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9165273pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9165273pubmed:statusMEDLINElld:pubmed
pubmed-article:9165273pubmed:issn0254-9670lld:pubmed
pubmed-article:9165273pubmed:authorpubmed-author:RöpkeCClld:pubmed
pubmed-article:9165273pubmed:authorpubmed-author:SvejgaardAAlld:pubmed
pubmed-article:9165273pubmed:authorpubmed-author:NielsenMMlld:pubmed
pubmed-article:9165273pubmed:authorpubmed-author:J?rgensenAAlld:pubmed
pubmed-article:9165273pubmed:authorpubmed-author:LedbetterJ...lld:pubmed
pubmed-article:9165273pubmed:authorpubmed-author:OdumNNlld:pubmed
pubmed-article:9165273pubmed:issnTypePrintlld:pubmed
pubmed-article:9165273pubmed:volume13lld:pubmed
pubmed-article:9165273pubmed:ownerNLMlld:pubmed
pubmed-article:9165273pubmed:authorsCompleteYlld:pubmed
pubmed-article:9165273pubmed:pagination192-203lld:pubmed
pubmed-article:9165273pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9165273pubmed:meshHeadingpubmed-meshheading:9165273-...lld:pubmed
pubmed-article:9165273pubmed:meshHeadingpubmed-meshheading:9165273-...lld:pubmed
pubmed-article:9165273pubmed:meshHeadingpubmed-meshheading:9165273-...lld:pubmed
pubmed-article:9165273pubmed:meshHeadingpubmed-meshheading:9165273-...lld:pubmed
pubmed-article:9165273pubmed:meshHeadingpubmed-meshheading:9165273-...lld:pubmed
pubmed-article:9165273pubmed:meshHeadingpubmed-meshheading:9165273-...lld:pubmed
pubmed-article:9165273pubmed:meshHeadingpubmed-meshheading:9165273-...lld:pubmed
pubmed-article:9165273pubmed:meshHeadingpubmed-meshheading:9165273-...lld:pubmed
pubmed-article:9165273pubmed:meshHeadingpubmed-meshheading:9165273-...lld:pubmed
pubmed-article:9165273pubmed:meshHeadingpubmed-meshheading:9165273-...lld:pubmed
pubmed-article:9165273pubmed:meshHeadingpubmed-meshheading:9165273-...lld:pubmed
pubmed-article:9165273pubmed:meshHeadingpubmed-meshheading:9165273-...lld:pubmed
pubmed-article:9165273pubmed:meshHeadingpubmed-meshheading:9165273-...lld:pubmed
pubmed-article:9165273pubmed:meshHeadingpubmed-meshheading:9165273-...lld:pubmed
pubmed-article:9165273pubmed:meshHeadingpubmed-meshheading:9165273-...lld:pubmed
pubmed-article:9165273pubmed:meshHeadingpubmed-meshheading:9165273-...lld:pubmed
pubmed-article:9165273pubmed:meshHeadingpubmed-meshheading:9165273-...lld:pubmed
pubmed-article:9165273pubmed:year1996lld:pubmed
pubmed-article:9165273pubmed:articleTitleHuman thymic epithelial cells present superantigens to T-cell lines and thymocytes.lld:pubmed
pubmed-article:9165273pubmed:affiliationInstitute of Medical Anatomy, University of Copenhagen, Panum Institute, Denmark.lld:pubmed
pubmed-article:9165273pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9165273pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed